Gupta VG, Hirst J, Petersen S, Roby KF, et al. Entinostat, a selective HDAC1/2 inhibitor, potentiates the effects of olaparib in homologous recombination proficient ovarian cancer. Gynecol Oncol 2021 Apr 15. pii: S0090-8258(21)00325.
PMID: 33867143